BR9714401A - Antìgenos de supefìcie de célula de mamìfero; regentes relacionados - Google Patents

Antìgenos de supefìcie de célula de mamìfero; regentes relacionados

Info

Publication number
BR9714401A
BR9714401A BR9714401-0A BR9714401A BR9714401A BR 9714401 A BR9714401 A BR 9714401A BR 9714401 A BR9714401 A BR 9714401A BR 9714401 A BR9714401 A BR 9714401A
Authority
BR
Brazil
Prior art keywords
cell surface
rulers
mammalian cell
surface antigens
reagents
Prior art date
Application number
BR9714401-0A
Other languages
English (en)
Inventor
Daniel M Gorman
Jeanine D Mattson
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21867133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9714401(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9714401A publication Critical patent/BR9714401A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção: <B>"ANTìGENOS DE SUPERFìCIE DE CéLULAS DE MAMìFERO; REAGENTES RELACIONADOS"<D>. Genes purificados codificando um antígeno de superfície de célula T de um mamífero, reagentes relacionados a eles incluindo proteínas purificadas, anticorpos específicos e ácidos nucléicos codificados este antígeno são providos. Métodos de uso dos ditos reagentes e kits de diagnóstico são providos.
BR9714401-0A 1996-12-13 1997-12-12 Antìgenos de supefìcie de célula de mamìfero; regentes relacionados BR9714401A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3284696P 1996-12-13 1996-12-13
PCT/US1997/022766 WO1998025958A2 (en) 1996-12-13 1997-12-12 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the tnf ligand family

Publications (1)

Publication Number Publication Date
BR9714401A true BR9714401A (pt) 2000-04-18

Family

ID=21867133

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714401-0A BR9714401A (pt) 1996-12-13 1997-12-12 Antìgenos de supefìcie de célula de mamìfero; regentes relacionados

Country Status (15)

Country Link
US (5) US6242586B1 (pt)
EP (5) EP0948530A2 (pt)
JP (6) JP2001506991A (pt)
CN (1) CN1245534A (pt)
AT (1) ATE399861T1 (pt)
AU (1) AU5697098A (pt)
BR (1) BR9714401A (pt)
CA (1) CA2274801C (pt)
DE (2) DE69738811D1 (pt)
DK (1) DK1114864T4 (pt)
ES (1) ES2305009T5 (pt)
HK (1) HK1034743A1 (pt)
LU (1) LU91756I2 (pt)
PT (1) PT1114864E (pt)
WO (1) WO1998025958A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7632922B1 (en) * 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
DE69738811D1 (de) * 1996-12-13 2008-08-14 Schering Corp Oberflächenantigene aus Säugern
EP0946725B1 (en) 1996-12-23 2011-01-26 Immunex Corporation Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
WO1999058674A2 (en) * 1998-05-14 1999-11-18 Immunex Corporation Method of inhibiting osteoclast activity
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
AU2008200700C1 (en) * 1997-04-15 2013-04-04 Daiichi Sankyo Co., Ltd Novel Protein and Process for Producing The Same
RU2238949C2 (ru) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
AU2011202547B2 (en) * 1997-04-16 2014-08-28 Amgen Inc. Osteoprotegerin binding proteins and receptors
EP0975754B2 (en) * 1997-04-16 2016-01-06 Amgen Inc., Osteoprotegerin binding proteins and their receptors
US5843678A (en) * 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
US6084926A (en) * 1997-12-08 2000-07-04 Ericsson Inc. Method and system for demodulating radio signals
US7063960B2 (en) 1997-12-12 2006-06-20 The Rockefeller University Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
EP1541587A3 (en) * 1998-09-15 2007-06-20 Pharmexa A/S Method for down-regulating osteoprotegerin ligand activity
SK3062001A3 (en) * 1998-09-15 2002-02-05 Pharmexa As Method for down-regulating osteoprotegerin ligand activity
WO2001062932A1 (en) † 2000-02-23 2001-08-30 Amgen Inc. Antagonistic selective binding agents of osteoprotegerin binding protein
US20030103978A1 (en) * 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
AU2001293030B2 (en) * 2000-09-22 2007-07-19 Immunex Corporation Screening assays for agonists or antagonists of receptor activat or of NF-kB
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
JP4761710B2 (ja) * 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
AU2003297833A1 (en) * 2002-12-10 2004-06-30 Schering-Plough Ltd. Canine rankl and methods for preparing and using the same
KR20070058426A (ko) * 2004-06-02 2007-06-08 사이토스 바이오테크놀로지 아게 비-인간 ｔｎｆ-펩티드의 담체 콘쥬게이트의 의학적 용도
US7582910B2 (en) * 2005-02-28 2009-09-01 The Regents Of The University Of California High efficiency light emitting diode (LED) with optimized photonic crystal extractor

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319315A (en) 1969-06-19 1973-06-06 Citizen Watch Co Ltd Calendar timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
DE69317883T2 (de) 1992-11-17 1998-11-12 Icos Corp Neue Sieben-Transmembran-Rezeptor V28
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
AU711141B2 (en) * 1995-04-07 1999-10-07 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6111090A (en) * 1996-08-16 2000-08-29 Schering Corporation Mammalian cell surface antigens; related reagents
DE69738811D1 (de) * 1996-12-13 2008-08-14 Schering Corp Oberflächenantigene aus Säugern
WO1999058674A2 (en) * 1998-05-14 1999-11-18 Immunex Corporation Method of inhibiting osteoclast activity
EP0946725B1 (en) * 1996-12-23 2011-01-26 Immunex Corporation Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
US6271349B1 (en) * 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
RU2238949C2 (ru) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
US5843678A (en) 1997-04-16 1998-12-01 Amgen Inc. Osteoprotegerin binding proteins
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
EP0975754B2 (en) * 1997-04-16 2016-01-06 Amgen Inc., Osteoprotegerin binding proteins and their receptors

Also Published As

Publication number Publication date
AU5697098A (en) 1998-07-03
PT1114864E (pt) 2008-10-08
EP1995318A1 (en) 2008-11-26
JP2008143906A (ja) 2008-06-26
CA2274801A1 (en) 1998-06-18
DE122010000046I1 (de) 2011-05-05
LU91756I2 (fr) 2011-01-24
EP1114864A3 (en) 2001-10-10
DE69738811D1 (de) 2008-08-14
EP1803816A2 (en) 2007-07-04
JP2013074899A (ja) 2013-04-25
JP2009254381A (ja) 2009-11-05
US7063841B2 (en) 2006-06-20
WO1998025958A2 (en) 1998-06-18
EP0948530A2 (en) 1999-10-13
ES2305009T5 (es) 2012-11-15
JP2001506991A (ja) 2001-05-29
HK1034743A1 (en) 2001-11-02
JP2010119397A (ja) 2010-06-03
EP1803816A3 (en) 2007-09-26
DK1114864T4 (da) 2012-09-03
US20090092597A1 (en) 2009-04-09
EP1114864B2 (en) 2012-07-25
EP1114864B1 (en) 2008-07-02
JP2010172336A (ja) 2010-08-12
CA2274801C (en) 2014-02-04
ES2305009T3 (es) 2008-11-01
US6525180B1 (en) 2003-02-25
WO1998025958A3 (en) 1998-07-30
EP1114864A2 (en) 2001-07-11
EP1995317B1 (en) 2014-11-05
EP1995317A1 (en) 2008-11-26
US6242586B1 (en) 2001-06-05
US20030144480A1 (en) 2003-07-31
CN1245534A (zh) 2000-02-23
EP1114864B9 (en) 2013-05-08
US20060025572A1 (en) 2006-02-02
ATE399861T1 (de) 2008-07-15
DK1114864T3 (da) 2008-10-06

Similar Documents

Publication Publication Date Title
DK0920505T3 (da) Pattedyrcelleoverfladeantigener og tilhörende reagenser
LU91756I2 (fr) Denosumab
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
MY157028A (en) Mammalian cytokine, related reagents
WO1997021812A3 (en) Mammalian chemokine ccf8 and chemokine receptor cckr3
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
ATE341626T1 (de) Membranproteine aus säugetierzellen; verwandte reagentien
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
AU5587298A (en) Isolated mammalian monocyte cell genes; related reagents
WO1998011226A3 (en) Mammalian chemokines, related reagents
WO1998039421A3 (en) Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
WO1998032858A3 (en) Mammalian chemokines; receptors; reagents; uses
ATE265533T1 (de) Saeugetierchemokine
MX9603266A (es) Genes de timocina de mamiferos.
EP0997476A3 (en) Antibodies to a mammalian Langerhans cell antigen and their uses
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
EP1867720A3 (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
WO2000034335A3 (en) &#39;death domain&#39; containing receptors
WO1998023747A3 (en) Isolated mammalian dendritic cell genes; related reagents
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.
ECSP982583A (es) Genes aislados de proteinas de membranas de mamiferos reactivos relacionados

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: A REQUERENTE APRESENTOU NOVO QUADRO REIVINDICATORIO COMPOSTO POR 24 (VINTE E QUATRO) REIVINDICACOES. ENTRETANTO, NAO APRESENTOU COMPROVACAO DA COMPLEMENTACAO DE RETRIBUICAO DEVIDA PELO EXAME DE 11 (ONZE) REIVINDICACOES EXCEDENTES. PORTANTO, A REQERENTE DEVERA COMPLEMENTAR A TAXA RELATIVA A 11 (ONZE) REIVINDICACOES EXCEDENTES.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 (IX), 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MERCK SHARP AND DOHME CORP. (US)

B25G Requested change of headquarter approved

Owner name: MERCK SHARP AND DOHME CORP. (US)